{"id":"https://openalex.org/W4252299596","doi":"https://doi.org/10.1093/neuonc/noz008","title":"Highlights from the Literature","display_name":"Highlights from the Literature","publication_year":2019,"publication_date":"2019-02-01","ids":{"openalex":"https://openalex.org/W4252299596","doi":"https://doi.org/10.1093/neuonc/noz008"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noz008","doi":"https://doi.org/10.1093/neuonc/noz008","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noz008","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/2/148/27779113/noz008.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/2/148/27779113/noz008.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044442671","display_name":"Roger Abounader","orcid":"https://orcid.org/0000-0003-4075-9460","observed_orcids":["https://orcid.org/0000-0003-4075-9460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger Abounader","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080482957","display_name":"Wolfgang Wick","orcid":"https://orcid.org/0000-0002-6171-634X","observed_orcids":["https://orcid.org/0000-0002-6171-634X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Wick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076042525","display_name":"Benjamin W. Purow","orcid":"https://orcid.org/0000-0001-7372-6062","observed_orcids":["https://orcid.org/0000-0001-7372-6062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Purow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024476694","display_name":"Jason T. Huse","orcid":"https://orcid.org/0000-0003-4514-0640","observed_orcids":["https://orcid.org/0000-0003-4514-0640","https://orcid.org/0000-0003-4933-9120"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Huse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082835319","display_name":"Elizabeth Robins Gerstner","orcid":"https://orcid.org/0000-0003-2382-3838","observed_orcids":["https://orcid.org/0000-0003-2382-3838"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Gerstner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34862761,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"2","first_page":"148","last_page":"150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8012999892234802,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8012999892234802,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.13660000264644623,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.8009999990463257},{"id":"https://openalex.org/keywords/2-hydroxyglutarate","display_name":"2-hydroxyglutarate","score":0.9300000071525574},{"id":"https://openalex.org/keywords/bcat1","display_name":"BCAT1","score":0.8149999976158142},{"id":"https://openalex.org/keywords/bcat2","display_name":"BCAT2","score":1.0},{"id":"https://openalex.org/keywords/branched-chain-amino-acids","display_name":"branched-chain amino acids","score":0.8569999933242798},{"id":"https://openalex.org/keywords/glutamate-synthesis","display_name":"glutamate synthesis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/glutathione","display_name":"glutathione","score":0.8859999775886536},{"id":"https://openalex.org/keywords/glutaminase","display_name":"glutaminase","score":0.8790000081062317},{"id":"https://openalex.org/keywords/glioma-metabolism","display_name":"glioma metabolism","score":0.7630000114440918},{"id":"https://openalex.org/keywords/metabolic-vulnerability","display_name":"metabolic vulnerability","score":0.6010000109672546},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.5740000009536743},{"id":"https://openalex.org/keywords/epigenetic-dysregulation","display_name":"epigenetic dysregulation","score":0.6690000295639038},{"id":"https://openalex.org/keywords/glutamine","display_name":"glutamine","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C39432304","wikidata":"https://www.wikidata.org/wiki/Q188847","display_name":"Environmental science","level":0,"score":0.3084404468536377}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noz008","doi":"https://doi.org/10.1093/neuonc/noz008","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noz008","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/2/148/27779113/noz008.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6374754","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6374754","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noz008","doi":"https://doi.org/10.1093/neuonc/noz008","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noz008","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/2/148/27779113/noz008.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4252299596.pdf","grobid_xml":"https://content.openalex.org/works/W4252299596.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2890911268","https://openalex.org/W4256673452","https://openalex.org/W4300868487","https://openalex.org/W3175081561","https://openalex.org/W2117950076","https://openalex.org/W2074983857","https://openalex.org/W2166138133","https://openalex.org/W2741733265","https://openalex.org/W2971604281","https://openalex.org/W2043720679"],"abstract_inverted_index":{"Isocitrate":[0],"dehydrogenase":[1],"1":[2],"(IDH1)":[3],"mutations":[4,194,504,2016],"are":[5,75,93,490,499,515,873,929,947,1243,1250,1335,1749,1764,2073],"found":[6,1087,1493,1534,1703],"in":[7,32,95,116,133,171,183,214,254,289,366,427,449,466,475,565,577,638,649,655,751,776,795,830,881,1019,1024,1037,1062,1116,1128,1153,1156,1163,1208,1251,1280,1317,1344,1370,1397,1539,1543,1622,1628,1676,1739,1752,1788,1960,1982,2046,2056,2075],"the":[8,33,49,55,58,78,84,104,117,149,151,241,249,339,342,363,382,398,467,500,506,531,548,560,596,627,639,666,672,683,690,717,721,733,741,757,815,827,831,842,856,875,882,987,1025,1038,1043,1059,1103,1131,1252,1309,1351,1403,1425,1454,1491,1544,1557,1564,1569,1581,1647,1650,1677,1681,1726,1773,1841,1844,1940,1950,1970,1983,2009,2036,2039,2047],"majority":[9],"of":[10,36,51,57,71,106,239,251,287,304,314,338,381,384,417,425,431,463,503,508,534,562,573,608,629,659,697,746,772,811,818,844,858,877,907,978,982,992,1001,1033,1042,1065,1184,1214,1314,1376,1380,1387,1405,1418,1428,1456,1473,1498,1571,1583,1617,1649,1759,1785,1843,1851,1887,1892,1900,1943,1949,1972,1987,1995,2008,2014,2028,2038,2049],"low-grade":[11],"gliomas":[12,1789],"and":[13,28,87,103,108,127,135,137,159,168,174,180,198,210,217,231,269,279,317,326,393,412,519,542,583,682,797,888,903,917,943,1007,1045,1048,1068,1085,1108,1155,1227,1294,1321,1347,1422,1462,1489,1593,1599,1642,1655,1668,1719,1742,1769,1798,1860,1895,1997,2067,2070],"secondary":[14,941,963,984,1020,1066,1129,1168,1215,1304,1319,1381],"glioblastoma.":[15,908,1305],"IDH1":[16,122,164,204,913],"mutants":[17,165,205,309],"convert":[18],"2-oxoglutarate":[19],"(2OG)":[20],"to":[21,30,130,276,284,311,377,409,615,693,756,781,806,836,869,968,995,1088,1257,1331,1535,1563,1589,1596,1691,1696,1723,1772,1808,1965,1968,2005,2021,2064],"2-hydroxyglutarate":[22],"(2HG),":[23],"which":[24,74,707,1500,1847],"inhibits":[25,125,157,178,405],"2OG-dependent":[26,43],"dioxygenases":[27],"leads":[29,283,310,376],"changes":[31],"epigenetic":[34],"landscape":[35,991,1404],"gliomas.":[37,442,1836],"However,":[38],"cells":[39,67,173,221,268,392,465,636,664,787],"also":[40,223,716,1012,1180,1228,1362,1414,1626,1737,1930],"have":[41,68,350,616,934,1296],"other":[42,662,812,944,1323,1377,2015],"enzymes,":[44],"including":[45,480,1004,1022,1832,1853],"transaminases":[46,85,92],"that":[47,64,90,121,142,155,163,175,192,203,244,265,280,302,318,346,359,401,728,965,1195,1267,1466,1556,1574,1604,1684,1704,1753,1763,1811,1824,1953,2017,2087],"catalyze":[48],"production":[50,56],"glutamate":[52,134,170,199,212,225,278,288,305,411],"needed":[53],"for":[54,248,334,421,439,473,485,626,792,1197,1246,1259,1282,1311,1440,1515,1611,1766,1903,2060,2093],"antioxidant":[59,340],"glutathione.":[60],"Previous":[61],"work":[62,590,598,762,1963],"showed":[63,301,358,400,1146,1175],"IDH":[65,96,193,255,266,290,294,308,335,385,389,402,440,1799],"mutant":[66,97,256,267,291,386,441,927,1384],"decreased":[69],"levels":[70,213,316,572],"branched-chain":[72,79],"\u03b1-ketoacids,":[73],"made":[76],"from":[77,226,459,711,732,839,900,953,1263,1481],"amino":[80],"acids":[81],"(BCAA)":[82],"by":[83,161,201,262,307,323,328,456,547,591,657,1057,1636,1792],"BCAT1":[86,107,126,158,179],"BCAT2,":[88,128],"suggesting":[89,1254],"these":[91,101,993,1122,1223,1287,1479,1927,1988,2071,2094],"inhibited":[94],"cells.":[98,257,847],"Based":[99],"on":[100,110,274,599,784,826,855,962,1525,1580,1588],"findings":[102,1748],"dependence":[105],"BCAT2":[109,160,181],"2OG,":[111],"a":[112,131,184,215,285,312,378,435,444,452,471,581,605,675,694,768,789,969,979,999,1134,1159,1205,1211,1230,1416,1445,1494,1711,1717,1756,1849,1882,1922,2023,2032,2083],"recent":[113,1398,1446],"study":[114,399,1346,1817,1823,1946,2086],"published":[115,448],"journal":[118],"Cell":[119],"hypothesized":[120,243],"mutant-derived":[123],"2HG":[124,156,176,404],"leading":[129,408],"decrease":[132,169,286],"glutathione":[136,315,413],"thus":[138,1276],"creating":[139],"metabolic":[140],"vulnerabilities":[141],"could":[143,1687],"be":[144,807,837,886,890,1124,1270,1329,1363,1688,1813,1958,1966,1979],"exploited":[145],"therapeutically.1":[146],"To":[147,1119],"verify":[148],"hypothesis,":[150],"authors":[152,242,343,603,691,974,1132,1492,1586,1682],"first":[153],"demonstrated":[154,191,1683],"showing":[162,202,264,1192,1952],"increase":[166,1115],"BCAAs":[167],"glioma":[172,391,902,1151,1741,1845,2076],"competitively":[177],"activities":[182],"recombinant":[185],"BCAT":[186,252,324,406,422],"activity":[187,253,1369],"assay.":[188],"They":[189,258,299,569,997],"then":[190,300,344],"impair":[195],"BCAA":[196,207],"catabolism":[197],"biosynthesis":[200],"inhibit":[206],"leucine":[208],"transamination":[209],"suppress":[211],"2HG-":[216],"BCAT-dependent":[218],"manner.":[219],"Since":[220,331],"can":[222,419],"make":[224],"glutamine":[227],"using":[228],"glutaminase":[229,418,426],"(GLS),":[230],"since":[232],"human":[233],"brain":[234,297,685,777,799,828,1225,1407,1475],"tumors":[235,270,829,994,1226,1561,1624,1920],"use":[236,533,876],"large":[237,980],"amounts":[238],"glutamine,":[240],"GLS":[245,275,281,329,332,347,360],"might":[246,349,1123],"compensate":[247,420],"loss":[250,783,2037],"proved":[259],"this":[260,319,630,752,761,1264,1345,1429,1945,2081],"hypothesis":[261],"experimentally":[263],"display":[271],"increased":[272],"reliance":[273],"produce":[277],"inactivation":[282],"but":[292,387,652,669,932,1010,1179,1286,1519,1715,1810],"not":[293,388,491,645,670,688,935,1016,1176,1657,1716,1913,2002],"wildtype":[295,390],"experimental":[296,394,759],"tumors.":[298,395,778],"inhibition":[303,325,337,348,361,380,424,745,860,1274,1373],"synthesis":[306],"reduction":[313,320],"was":[321,687,1056,1069,1086,1342,1818,2001],"mediated":[322],"rescued":[327],"overexpression.":[330],"compensates":[333],"mutant-induced":[336],"glutathione,":[341],"speculated":[345,558],"anti-glioma":[351,488],"effects":[352],"under":[353],"oxidative":[354,374,432],"stress.":[355],"Accordingly,":[356],"they":[357,633,933,1011,1702,1754],"with":[362,368,429,477,521,536,567,580,610,737,841,1071,1098,1113,1139,1165,1170,1186,1189,1237,1284,1302,1353,1374,1431,1560,1568,1710,1725,1733,1829,1835,1867,1881,1907,1918,2096],"drug":[364],"CB-839":[365],"combination":[367,428],"oxygen-,":[369],"tert-butyl":[370],"oxidant-,":[371],"or":[372,661,914,1249,1337,1386,1873,2012,2044],"radiation-induced":[373],"stress":[375,433],"strong":[379],"growth":[383],"In":[396,443,623,720,754,1444,1477,2079],"summary,":[397,2080],"mutation-induced":[403],"transaminases,":[407],"impaired":[410],"synthesis.":[414],"As":[415,866],"activation":[416],"inhibition,":[423,2069],"induction":[430],"represents":[434,1436],"new":[436,951,959,970,1231,2090],"therapeutic":[437,971,1232,1255,1693],"strategy":[438],"current":[445,483,589,883],"translational":[446],"paper":[447],"Nature":[450,1447],"Medicine,":[451],"multi-center":[453],"group":[454,1665,1743],"led":[455],"Peter":[457],"Fecci":[458],"Duke":[460],"postulates":[461],"sequestration":[462,681,750,766],"T":[464,538,635,679,734,764,773,786,846],"bone":[468,640,718],"marrow":[469],"as":[470,767,814,834,861,863,879,1204,1325,1341,1348,1392,1663,1790,2034,2052,2077],"reason":[472],"lymphocytopenia":[474],"patients":[476,566,609,1164,1188,1283,1301,1834,1928,1989,2095],"intracranial":[478,667,742],"neoplasms":[479],"glioblastoma.1":[481],"The":[482,494,588,602,779,848,973,1585,1815,1877],"obstacles":[484],"an":[486,853,1114,1290,1437,1783,1819,1955],"effective":[487,1441],"immunotherapy":[489,894],"fully":[492],"elucidated.":[493],"main":[495],"factors":[496,528],"usually":[497],"discussed":[498],"low":[501,618],"number":[502,843,1000,1417,1942],"limiting":[505],"amount":[507],"putatively":[509,798],"more":[510,1080,1923],"immunogenic":[511],"neo-antigens.2":[512],"Further,":[513],"glioblastomas":[514],"considered":[516,891],"immunologically":[517],"resistant":[518],"\u201ccold\u201d,":[520],"limited":[522,1807,2097],"intra-tumoral":[523],"immune":[524,793],"cell":[525,539,680,735,765,774,1464,1517,1594],"infiltration.3":[526],"Other":[527,1234],"may":[529,885,1269,1812,1957,2018],"include":[530],"prevalent":[532],"steroids":[535],"their":[537,624,1547,1591,1612,1629,1685],"cytotoxic":[540,549],"properties":[541],"reduced":[543],"lymphocyte":[544,709],"counts":[545,620],"exerted":[546],"treatment.":[550,587],"Already":[551],"some":[552,650,1181],"years":[553,1399],"ago":[554],"Grossman":[555],"et":[556,593,725,955,1451,1838],"al.":[557,726,956,1452],"about":[559,905,1222],"relevance":[561],"treatment-associated":[563],"immunosuppression":[564],"glioblastoma.4":[568],"described":[570,880],"starting":[571],"664":[574],"CD4+":[575],"cells/mm3":[576],"96":[578],"patients,":[579,651,1944],"severe":[582],"persistent":[584],"drop":[585],"during":[586],"Chongsathidkiet":[592,724],"al":[594,1839],"excels":[595],"prior":[597,695,2057],"many":[600],"levels.1":[601],"describe":[604],"15%":[606],"cohort":[607,1545,1758],"glioblastoma":[611,660,796,898,964,1320],"(and":[612,714],"tumor-bearing":[613],"mice)":[614],"extremely":[617],"CD4":[619],"(\u2264200":[621],"cell/mm3).":[622],"search":[625],"cause":[628],"pretreatment":[631],"lymphocytopenia,":[632],"observed":[634,1018],"sequestered":[637],"marrow.":[641],"This":[642,801,1173,1200,1306],"phenomenon":[643],"is":[644,653,730,835,921,1349,1367,1947,2031,2035,2082],"only":[646,1177,1339],"naturally":[647],"present":[648,722,1755],"inducible":[654],"mice":[656],"implantation":[658],"cancer":[663,1827],"into":[665,671,740,809],"compartment,":[668],"periphery.":[673],"Although":[674],"functional":[676],"link":[677,780],"between":[678,1487,1502,1513,1522],"neoplastic":[684],"lesion":[686],"established,":[689],"refer":[692],"observation":[696],"sphingosine":[698],"1-phosphate":[699],"(S1P)":[700],"/":[701],"S1P":[702],"receptor":[703],"(S1P1)":[704],"gradient":[705],"disruption,":[706],"prevents":[708,749],"egress":[710],"lymphoid":[712],"organs5":[713],"now":[715],"marrow).":[719],"paper,":[723],"demonstrate":[727],"S1P1":[729,747,782,820,849,871],"lost":[731],"surface":[736],"tumor":[738,1433,1484,1503,1508,1549,1660],"inoculation":[739],"compartment.":[743],"Genetic":[744],"internalization":[748,821,850],"model.":[753],"addition":[755],"fine":[758],"data,":[760],"introduces":[763],"potential":[769,802,1206,1378,1388],"additional":[770],"mode":[771],"dysfunction":[775],"na\u00efve":[785,845],"provides":[788,957],"novel":[790,1135,1219,1419],"target":[791,2029,2040],"intervention":[794,817],"metastases.":[800],"use,":[803],"however,":[804],"needs":[805,1964],"put":[808],"perspective":[810],"treatments,":[813],"mono":[816],"preventing":[819],"had":[822,852,1297,1575,1990],"no":[823,1935],"relevant":[824],"impact":[825,854],"model":[832,1434,1651,1678],"described,":[833],"expected":[838,1002],"interfering":[840],"blockade":[851,1375],"efficacy":[857,939],"checkpoint":[859],"well":[862],"CD137":[864],"agonism.":[865],"pharmacological":[867],"tools":[868],"prevent":[870],"down-regulation":[872],"lacking,":[874],"G-CSF,":[878],"article,":[884],"attractive":[887],"should":[889,1361,1975],"when":[892],"discussing":[893],"adjunct":[895],"measures.":[896],"Secondary":[897],"arises":[899],"lower-grade":[901],"comprises":[904],"10%":[906],"While":[909],"it":[910,920],"often":[911,1350],"has":[912,1275,1400,1781,1805,2053,2062],"IDH2":[915],"mutation":[916,2011],"improved":[918],"prognosis,":[919],"still":[922],"universally":[923],"lethal.":[924],"Therapies":[925],"targeting":[926,1260,1795,1954,1977,2022],"IDH1/2":[928],"being":[930],"developed,":[931],"yet":[936],"shown":[937],"significant":[938,1751,1802],"against":[940,1149,1357],"glioblastoma,":[942,1067,1130,1216,1285,1382],"treatment":[945,1724,1978,2091,2098],"approaches":[946,1356],"desperately":[948],"needed.":[949],"A":[950],"report":[952,1201,1265,1307,1453,1840],"Hu":[954],"important":[958,1330,1438],"biological":[960,1220],"information":[961,1221],"gives":[966],"rise":[967],"strategy.1":[972],"performed":[975],"DNA":[976,1637],"sequencing":[977,1598,1971],"set":[981],"188":[983],"glioblastomas,":[985],"providing":[986,1229],"most":[988,1060],"extensive":[989],"genetic":[990,1014,1608],"date.":[996],"identified":[998,1621,1627],"elements,":[1003],"IDH1,":[1005,1385],"TP53,":[1006],"ATRX":[1008],"mutations,":[1009,1831],"noted":[1013],"aberrations":[1015],"previously":[1017],"glioblastoma\u2014prominently":[1021],"lesions":[1023,1127],"MET":[1026,1034,1046,1050,1052,1074,1090,1093,1104,1109,1136,1171,1203,1235,1273,1315,1372],"oncogene.":[1027],"Three":[1028],"were":[1029,1111,1533,1625,1634,1674,1736,1865,1879,1929,1934],"identified:":[1030],"1)":[1031],"skipping":[1032,1055,1077,1107],"exon":[1035,1053,1075,1099,1105],"14":[1036,1054,1076,1100,1106,1469],"transcript;":[1039],"2)":[1040],"fusions":[1041,1094,1110],"PTPRZ1":[1044],"genes;":[1047],"3)":[1049],"amplification.":[1051],"far":[1058,1277],"common,":[1061],"approximately":[1063],"14%":[1064],"associated":[1070,1112],"poor":[1072],"prognosis.":[1073],"occurred":[1078,1096],"through":[1079,1992,2041],"than":[1081],"one":[1082,1948],"mutational":[1083],"mechanism":[1084],"prolong":[1089],"protein":[1091],"half-life.":[1092],"frequently":[1095],"simultaneously":[1097],"skipping.":[1101],"Interestingly,":[1102],"tumor-associated":[1117],"macrophages.":[1118],"test":[1120],"whether":[1121,1365],"targetable":[1125],"driver":[1126,1207],"used":[1133,1980],"kinase":[1137],"inhibitor":[1138,1729],"good":[1140,1238],"blood-brain":[1141],"barrier":[1142],"permeability,":[1143],"PLB-1001.":[1144],"PLB-001":[1145,1258,1268],"preclinical":[1147,1442,1767],"promise":[1148],"MET-driven":[1150],"lines":[1152,1465,1523,1532,1595,1994],"vitro":[1154],"vivo,":[1157],"prompting":[1158],"phase":[1160],"I":[1161],"trial":[1162,1174],"pretreated,":[1166],"recurrent":[1167],"GBM":[1169],"lesions.":[1172],"safety":[1178],"preliminary":[1182],"signs":[1183],"efficacy,":[1185],"two":[1187,1705],"advanced":[1190],"disease":[1191,1420,1566,1761,1870,1984],"partial":[1193],"responses":[1194,1334],"lasted":[1196],"20":[1198],"weeks.":[1199],"establishes":[1202],"at":[1209],"least":[1210],"substantial":[1212],"subset":[1213],"yielding":[1217],"valuable":[1218],"lethal":[1224],"option.":[1233],"inhibitors":[1236,1316],"central":[1239],"nervous":[1240],"system":[1241],"penetration":[1242],"already":[1244],"FDA-approved":[1245],"non-neuro-oncological":[1247],"indications":[1248],"pipeline,":[1253],"alternatives":[1256],"MET\u2014although":[1261],"data":[1262],"suggest":[1266],"superior.":[1271],"Notably,":[1272],"proven":[1278],"disappointing":[1279],"trials":[1281,1288,1313],"included":[1289],"unselected":[1291],"patient":[1292],"population":[1293],"would":[1295],"few":[1298,1951],"if":[1299,1333],"any":[1300],"MET-altered":[1303,1318],"suggests":[1308],"need":[1310],"larger":[1312,1774],"raises":[1322],"questions":[1324],"well.":[1326,2078],"It":[1327,1360],"will":[1328],"determine":[1332,1969,2006],"durable":[1336],"last":[1338],"months,":[1340,1894],"seen":[1343,1738,2055],"case":[1352],"precision":[1354],"medicine":[1355],"adaptable":[1358],"cancers.":[1359],"evaluated":[1364],"there":[1366],"combinatorial":[1368],"combining":[1371,2065],"drivers":[1379],"e.g.":[1383,1974],"resistance":[1389],"mediators":[1390],"such":[1391,1662],"PI3":[1393],"kinase.":[1394],"Molecular":[1395],"profiling":[1396,1554],"dramatically":[1401],"clarified":[1402],"pediatric":[1406,1474],"tumors,":[1408],"refining":[1409],"established":[1410],"classification":[1411],"schemes":[1412],"while":[1413],"designating":[1415],"entities":[1421],"subtypes.":[1423],"Capturing":[1424],"full":[1426],"extent":[1427],"heterogeneity":[1430,2027],"tractable":[1432],"systems":[1435],"prerequisite":[1439],"testing.":[1443],"Medicine":[1448],"publication,":[1449],"Brabetz":[1450],"characterization":[1455],"30":[1457],"patient-derived":[1458],"orthotopic":[1459],"xenograft":[1460],"models":[1461,1480,1606,1686,1762],"7":[1463],"together":[1467],"represent":[1468],"distinct":[1470,1712],"molecular":[1471,1528,1613,1698],"subgroups":[1472],"tumors.1":[1476],"generating":[1478],"freshly":[1482],"obtained":[1483,1635],"tissue":[1485,1999],"collected":[1486],"2009":[1488],"2014,":[1490],"general":[1495],"engraftment":[1496],"rate":[1497,1886],"37%,":[1499],"varied":[1501,1520],"type.":[1504],"After":[1505],"serial":[1506],"passaging,":[1507],"latency":[1509],"became":[1510],"nearly":[1511],"identical":[1512],"animals":[1514],"each":[1516],"line,":[1518],"considerably":[1521],"based":[1524],"histology":[1526],"and/or":[1527],"subtype.":[1529,1614],"Virtually":[1530],"all":[1531,1605,1618,1904],"regrow":[1536],"after":[1537],"cryopreservation":[1538],"liquid":[1540],"nitrogen.":[1541],"Xenografts":[1542],"resembled":[1546],"parental":[1548],"histopathologically.":[1550],"Moreover,":[1551,2026],"global":[1552,1640],"methylation":[1553],"revealed":[1555],"xenografts":[1558,1592,1708],"clustered":[1559],"corresponding":[1562],"appropriate":[1565,1610],"subclasses,":[1567],"exception":[1570],"three":[1572],"cases":[1573],"been":[1576,1782,1806,1991,2054],"inappropriately":[1577],"classified":[1578],"initially":[1579],"basis":[1582],"histopathology.":[1584],"went":[1587],"subject":[1590],"whole-exome":[1597],"low-coverage":[1600],"whole-genome":[1601],"sequencing,":[1602],"finding":[1603],"harbored":[1607],"alterations":[1609],"Additionally,":[1615],"~98%":[1616],"single-nucleotide":[1619],"variants":[1620],"parent":[1623],"respective":[1630],"models.":[1631,1746],"Similar":[1632],"results":[1633,1732,1842,1878],"copy":[1638],"number,":[1639],"methylation,":[1641],"gene":[1643],"expression":[1644,2030],"analyses,":[1645],"emphasizing":[1646],"fidelity":[1648],"systems.":[1652],"Of":[1653],"note,":[1654],"perhaps":[1656],"surprisingly,":[1658],"aggressive":[1659],"types":[1661,1828],"MYC-amplified":[1664],"3":[1666,1744],"medulloblastoma":[1667,1673,1707,1745],"MYCN-amplified":[1669],"sonic":[1670],"hedgehog":[1671],"(SHH)":[1672],"overrepresented":[1675],"cohort.":[1679],"Finally,":[1680],"effectively":[1689],"employed":[1690],"identify":[1692],"regimens":[1694],"targeted":[1695,1779,2050],"specific":[1697],"profiles.":[1699],"For":[1700],"instance,":[1701],"SHH":[1706],"(each":[1709],"PTCH1":[1713],"mutation),":[1714],"MYCN":[1718],"GLI2-amplified":[1720],"xenograft,":[1721],"responded":[1722],"smoothened":[1727],"(SMO)":[1728],"vismodegib.":[1730],"Analogous":[1731],"different":[1734],"drugs":[1735],"high-grade":[1740,1854],"These":[1747],"highly":[1750],"well-validated":[1757],"viable":[1760],"optimized":[1765],"studies":[1768,1794,2072],"readily":[1770],"available":[1771],"research":[1775,1787],"community":[1776],"(http://www.r2platform.com/pdexplorer).":[1777],"Molecularly":[1778],"therapy":[1780],"area":[1784],"active":[1786],"exemplified":[1791],"multiple":[1793,1826],"EGFR":[1796],"amplification":[1797],"mutations.":[1800],"Unfortunately,":[1801],"clinical":[1803],"benefit":[1804],"date,":[1809],"changing.":[1814],"VE-BASKET":[1816],"international,":[1820],"open-label,":[1821],"nonrandomized":[1822],"enrolled":[1825,1848],"BRAFV600":[1830],"24":[1833],"Kaley":[1837],"cohort,":[1846],"variety":[1850],"histologies,":[1852],"gliomas,":[1855],"pilocytic":[1856],"astrocytomas,":[1857],"anaplastic":[1858],"ganglioglioma,":[1859],"pleomorphic":[1861],"xanthoastrocytoma":[1862],"(PXA).1":[1863],"Patients":[1864,1906],"treated":[1866],"vemurafenib":[1868],"until":[1869],"progression,":[1871],"withdrawal,":[1872],"intolerable":[1874],"adverse":[1875,1937],"effects.":[1876],"promising,":[1880],"confirmed":[1883],"objective":[1884],"response":[1885,1925,2020],"25%,":[1888],"median":[1889,1896],"progression-free":[1890],"survival":[1891,1898],"5.5":[1893],"overall":[1897],"(OS)":[1899],"28.2":[1901],"months":[1902],"patients.":[1905],"PXA":[1908],"particularly":[1909],"benefited":[1910],"(median":[1911],"OS":[1912],"reached":[1914],"yet),":[1915],"whereas":[1916],"those":[1917],"higher-grade":[1919],"experienced":[1921],"variable":[1924],"(although":[1926],"heavily":[1931],"pre-treated).":[1932],"There":[1933],"unexpected":[1936],"events.":[1938],"Despite":[1939],"small":[1941],"oncogene":[1956],"efficacious":[1959],"glioma.":[1961],"More":[1962],"done":[1967,2004],"treatment;":[1973],"BRAF":[1976,2010],"earlier":[1981],"course?":[1985],"Most":[1986],"several":[1993],"treatment,":[1996],"repeat":[1998],"sampling":[2000],"routinely":[2003],"persistence":[2007],"accumulation":[2013],"affect":[2019],"single":[2024],"mutation.":[2025],"concern":[2033],"Darwinian":[2042],"pressure":[2043],"even":[2045],"absence":[2048],"therapy,":[2051],"studies.2":[2058],"Treatment":[2059],"melanoma":[2061],"moved":[2063],"RAF":[2066],"MEK":[2068],"ongoing":[2074],"promising":[2084],"proof-of-concept":[2085],"opens":[2088],"up":[2089],"options":[2092],"choices.":[2099]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-05-12T00:00:00"}